In the media

19  Feb

Press review

From Monday to Friday, the Inserm press office offers a summary of the daily press (only available in French)

Today's review

What's on?

“Fake news” and misinformation around the SARS-CoV2 coronavirus

L'épidémie SARS-CoV2 n'échappe pas aux rumeurs et fausses informations. ...

Press Releases Tous les communiqués

Diabetes: the Gut Flora Yields Its Secrets for the Development of New Treatments

An organic compound produced by the gut flora – the metabolite 4-Cresol – is considered to have protective effects against both type 1 and 2 ...

PTSD: Resilience after trauma: the role of memory suppression

The terrorist attacks committed in Paris and Saint-Denis on November 13, 2015 have left lasting marks, not only on the survivors and their loved ones, ...

La première classification moléculaire des tumeurs hypophysaires ouvre de multiples champs de recherche

Les tumeurs hypophysaires disposent désormais d’une classification moléculaire précise, complète et objective, avec la perspective de mieux prédire et comprendre le comportement de certains sous-types ...

Human Textiles to Repair Blood Vessels

The leading cause of mortality worldwide, cardiovascular diseases claim over 17 million lives each year, according to World Health Organization estimates. To open up new ...

Videos

Quatre cafés par jour, vraiment ?

Informations multiples

News in brief

Publications

 
Inserm by the numbers
With a budget of 957 million euros in 2017, Inserm supports more than 300 laboratories across France.
Inserm by the numbers
fermer
fermer
RSS Youtube